Form 4: Oracle Director Michael J. Boskin Reports Significant Stock Transactions, Including RSU Conversion and Share Sale

Oracle Corp. Director Michael J. Boskin reported the exercise of restricted stock units, acquisition of new units, and a substantial sale of common stock on May 31, 2025.

Summary

• Director Michael J. Boskin of Oracle Corp. (ORCL) reported multiple transactions on May 31, 2025, as detailed in a Form 4 filing.
• He exercised 2,986 Restricted Stock Units (RSUs), converting them into 2,986 shares of Oracle common stock.
• Concurrently, Mr. Boskin disposed of 95,444 shares of Oracle common stock.
• He also acquired 2,114 new Restricted Stock Units (RSUs), which represent the right to receive one share of common stock upon settlement.
• The reported RSUs vested 100% on their first anniversary of the grant date.
• Following these transactions, Mr. Boskin directly beneficially owns 1,000 shares of common stock and indirectly owns 1,000 shares through his spouse.

Sentiment

Score: 5

Explanation: The document is a routine insider transaction report. While a large sale could be seen negatively, it's often for personal financial planning and balanced by new RSU grants. It's neutral in terms of company performance.

Positives

• Acquisition of 2,114 new Restricted Stock Units (RSUs) indicates continued equity compensation for the director, aligning his interests with shareholders.
• Exercise of 2,986 RSUs demonstrates the vesting and realization of previously granted equity compensation, a standard part of executive remuneration.

Negatives

• Disposition of 95,444 shares of common stock by a director could be perceived negatively by the market, potentially signaling a lack of confidence or a need for liquidity, although such sales are often for personal financial planning.

Risks

• Large insider sales, such as the disposition of 95,444 shares by a director, can sometimes be interpreted by the market as a negative signal, potentially leading to downward pressure on the stock price or investor concern.

Future Outlook

The document does not provide forward-looking statements or guidance regarding the company's future performance, focusing solely on insider stock transactions.

Industry Context

This Form 4 filing details routine insider stock transactions for a director at a major technology company, Oracle Corp. Such transactions are common for executives and directors managing their equity compensation and personal portfolios. The scale of the sale (95,444 shares) is notable for an individual director, but without context of total holdings or compensation structure, its broader industry implications are limited. It reflects standard practices of equity vesting and subsequent liquidity events within the tech sector.

Comparison to Industry Standards

• Insider transactions, including RSU conversions and subsequent share sales, are standard practices across the technology industry for directors and executives.
• The specific volume of shares disposed of (95,444) by Director Michael J. Boskin is significant for an individual, but without knowing his total compensation package or prior holdings, it's difficult to benchmark against specific comparable companies like Microsoft, IBM, or Salesforce.
• Generally, directors often sell shares to diversify their portfolios or for personal financial planning, which is a common occurrence in publicly traded companies.

Stakeholder Impact

• Shareholders: The disposition of a significant number of shares by a director could potentially be viewed as a negative signal, though it is a common practice for personal financial management.
• Employees: No direct impact on employees is indicated by this filing.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.

Next Steps

• The document does not outline specific future actions or milestones for the company, focusing solely on past insider transactions.

Key Dates

Keywords

Oracle, ORCL, SEC Form 4, Insider Trading, Stock Transaction, Restricted Stock Units, RSU, Director, Share Sale, Equity Compensation